Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Equity Income: 2021-2022

Historic Equity Income for ProQR Therapeutics N.V (PRQR) over the last 1 years, with Mar 2022 value amounting to -$8,979.

  • ProQR Therapeutics N.V's Equity Income fell 106.96% to -$8,979 in Q1 2022 from the same period last year, while for Mar 2022 it was -$519,596, marking a year-over-year change of. This contributed to the annual value of -$8,162 for FY2022, which is 96.82% up from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Equity Income of -$8,979 as of Q1 2022, which was up 90.77% from -$97,238 recorded in Q4 2021.
  • In the past 5 years, ProQR Therapeutics N.V's Equity Income ranged from a high of $129,067 in Q1 2021 and a low of -$257,714 during Q2 2021.
  • Its 2-year average for Equity Income is -$78,106, with a median of -$97,238 in 2021.
  • Data for ProQR Therapeutics N.V's Equity Income shows a maximum YoY tumbled of 106.96% (in 2022) over the last 5 years.
  • ProQR Therapeutics N.V's Equity Income (Quarterly) stood at -$97,238 in 2021, then crashed by 106.96% to -$8,979 in 2022.
  • Its last three reported values are -$8,979 in Q1 2022, -$97,238 for Q4 2021, and -$155,666 during Q3 2021.